Photo taken from: nib.com.au
Nov 14, 2023, 00:54
Edward Cliff: We highlight the overuse of terms such as ‘tolerable’, ‘manageable’ and ‘acceptable’ in reports of clinical trials
Edward Cliff, Fellow at Harvard Medical School and Brigham & Women’s Hospital, made the following post on LinkedIn:
“Pleased to share our manuscript just out in JAMA Network Open, where we highlight the overuse of terms such as ‘tolerable’, ‘manageable’ and ‘acceptable’ in reports of clinical trials, and show that the use of these terms does not correlate with the actual rates of serious adverse events. We must encourage honest reporting of AEs and increased use and reporting of patient-reported outcomes.
Well done Mimi Najjar!”
Source: Edward Cliff/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 19, 2024, 09:53
Nov 19, 2024, 09:44
Nov 19, 2024, 09:40
Nov 19, 2024, 09:28
Nov 19, 2024, 09:16
Nov 19, 2024, 02:34